Acadia Healthcare (NASDAQ:ACHC) Given Neutral Rating at Cantor Fitzgerald

Acadia Healthcare (NASDAQ:ACHC)‘s stock had its “neutral” rating restated by stock analysts at Cantor Fitzgerald in a research report issued on Tuesday, Benzinga reports. They presently have a $90.00 price target on the stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 36.36% from the company’s previous close.

ACHC has been the topic of a number of other research reports. Barclays decreased their target price on shares of Acadia Healthcare from $91.00 to $89.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 15th. Royal Bank of Canada reiterated an “outperform” rating and issued a $94.00 price objective on shares of Acadia Healthcare in a report on Wednesday, May 22nd. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 target price for the company in a report on Thursday, April 25th. StockNews.com cut Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Tuesday, May 21st. Finally, TheStreet raised Acadia Healthcare from a “c” rating to a “b-” rating in a research note on Monday, March 4th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $87.56.

Acadia Healthcare Price Performance

ACHC stock traded down $1.01 during mid-day trading on Tuesday, hitting $66.00. 198,324 shares of the stock were exchanged, compared to its average volume of 719,900. The business has a fifty day moving average price of $68.38 and a 200 day moving average price of $75.79. Acadia Healthcare has a 12 month low of $62.04 and a 12 month high of $87.77. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.27 and a quick ratio of 1.27. The stock has a market capitalization of $6.12 billion, a price-to-earnings ratio of -472.97, a PEG ratio of 2.03 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Thursday, May 2nd. The company reported $0.84 earnings per share for the quarter, topping analysts’ consensus estimates of $0.80 by $0.04. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. The company had revenue of $768.10 million during the quarter, compared to the consensus estimate of $779.20 million. During the same quarter in the previous year, the company posted $0.75 EPS. Acadia Healthcare’s quarterly revenue was up 9.1% compared to the same quarter last year. On average, sell-side analysts anticipate that Acadia Healthcare will post 3.52 EPS for the current year.

Hedge Funds Weigh In On Acadia Healthcare

Hedge funds and other institutional investors have recently made changes to their positions in the business. Cetera Advisors LLC purchased a new position in Acadia Healthcare during the 1st quarter valued at $540,000. Iron Triangle Partners LP raised its stake in Acadia Healthcare by 14.0% in the first quarter. Iron Triangle Partners LP now owns 902,813 shares of the company’s stock worth $71,521,000 after buying an additional 110,820 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in Acadia Healthcare by 2.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 133,093 shares of the company’s stock worth $10,545,000 after buying an additional 2,584 shares during the period. MQS Management LLC bought a new stake in Acadia Healthcare during the 1st quarter valued at approximately $322,000. Finally, CANADA LIFE ASSURANCE Co grew its holdings in shares of Acadia Healthcare by 14.7% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 58,505 shares of the company’s stock worth $4,637,000 after acquiring an additional 7,491 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.